Pharmacokinetic/pharmacodynamic (PK/PD) model for tolvaptan (TOL) in patients with congestive heart failure (CHF) and/or hyponatremia (HYP)

被引：0

作者：

Van Wart, SA ^{[1
]}

Cirincione, BB ^{[1
]}

Ludwig, EA ^{[1
]}

Chen, X ^{[1
]}

Shoaf, S ^{[1
]}

Grasela, TH ^{[1
]}

Mallikaarjun, S ^{[1
]}

机构：

[1] Cognigen Corp, Otsuka Maryland Res Inst, Buffalo, NY USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期

关键词：

D O I：

10.1016/j.clpt.2005.12.002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：P1 / P1

页数：1

共 50 条

[1] Pharmacokinetic-Pharmacodynamic (PK-PD) Model for Tolvaptan in Patients with Hypervolemic Hyponatremia
Van Wart, Scott
Shoaf, Susan
Mallikaarjun, Suresh
Mager, Donald
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S76 - S76
[2] Pharmacokinetic/pharmacodynamic (PK/PD) model for tolvaptan (TOL) in healthy subjects.
Van Wart, SA
Cirincione, BB
Ludwig, EA
Chen, X
Shoaf, S
Grasela, TH
Mallikaarjun, S
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P60 - P60
[3] TOLVAPTAN FOR THE TREATMENT OF HYPONATREMIA AND CONGESTIVE HEART FAILURE
Ferrer, E.
DRUGS OF TODAY, 2010, 46 (03) : 163 - 171
[4] Tolvaptan for the treatment of hyponatremia and hypervolemia in patients with congestive heart failure
Hori, Masatsugu
FUTURE CARDIOLOGY, 2013, 9 (02) : 163 - 176
[5] Tolvaptan for the treatment of hyponatremia and congestive heart failure
Orlandi, Cesare
Zimmer, Christopher A.
Gheorghiade, Mihai
FUTURE CARDIOLOGY, 2006, 2 (06) : 627 - 634
[6] Population pharmacokinetics/pharmacodynamics (PK/PD) of nesiritide in patients with congestive heart failure (CHF).
Sambol, NC
Liu, CY
Horton, D
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P90 - P90
[7] THE EFFICACY AND SAFETY OF TOLVAPTAN ON TREATING CONGESTIVE HEART FAILURE PATIENTS WITH HYPONATREMIA
Li Ling
Zhu Wen-ling
Bai Hua
HEART, 2011, 97
[8] THE EFFICACY AND SAFETY OF TOLVAPTAN ON TREATING CONGESTIVE HEART FAILURE PATIENTS WITH HYPONATREMIA
Li Ling
Zhu Wenling
Bai Hua
HEART, 2011, 97
[9] Pharmacokinetics and pharmacodynamics (PK/PD) of human brain natriuretic peptide (hBNP) in patients with congestive heart failure (CHF).
Kastrissios, H
Katz, SD
Grossbard, EB
Allgren, RL
Sambol, NC
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PIV47 - PIV47
[10] Usefulness of the Long-Term Tolvaptan for the Congestive Heart Failure (CHF)
Iwaki, Taku
JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S187 - S187

← 1 2 3 4 5 →